M
Marc Colonna
Researcher at Centre Hospitalier Universitaire de Grenoble
Publications - 146
Citations - 5244
Marc Colonna is an academic researcher from Centre Hospitalier Universitaire de Grenoble. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 33, co-authored 139 publications receiving 4697 citations. Previous affiliations of Marc Colonna include University of Grenoble.
Papers
More filters
Journal Article
Cancer incidence and mortality in France over the period 1978-2000
Laurent Remontet,J. Estève,Anne Marie Bouvier,Pascale Grosclaude,Guy Launoy,Menegoz F,C. Exbrayat,B. Tretare,P.M. Carli,A.V. Guizard,Xavier Troussard,Paolo Bercelli,Marc Colonna,J.M. Halna,G. Hedelin,J Mace-Lesec'h,J. Peng,A. Buemi,Michel Velten,Eric Jougla,Patrick Arveux,L. Le Bodic,E. Michel,M. Sauvage,Claire Schvartz,Jean Faivre +25 more
TL;DR: A striking divergence between incidence and mortality trends is observed for a great number of cancers, and prostate cancer shares with breast cancer the same pattern of a severe increasing incidence and a stable mortality.
Iconographies supplémentaires de l'article : Cancer incidence and mortality in France over the period 1980–2005
Aurélien Belot,Pascale Grosclaude,Nadine Bossard,Eric Jougla,Ellen Benhamou,Patricia Delafosse,A.V. Guizard,Florence Molinié,Arlette Danzon,Simona Bara,Anne Marie Bouvier,Brigitte Trétarre,F. Binder-Foucard,Marc Colonna,L. Daubisse,G. Hedelin,Guy Launoy,N. Le Stang,Marc Maynadié,Alain Monnereau,Xavier Troussard,Jean Faivre,Albert Collignon,I. Janoray,Patrick Arveux,A. Buemi,N. Raverdy,Claire Schvartz,M. Bovet,L. Chérié-Challine,J. Estève,Laurent Remontet,Michel Velten +32 more
TL;DR: In this paper, the authors provided updated estimates of national trends in cancer incidence and mortality for France for 1980-2005 for 25 cancer sites and found that the number of new cancer cases in 2005 was approximately 320,000, which corresponds to an 89% increase since 1980.
Journal ArticleDOI
Cancer incidence and mortality in France over the period 1980–2005
Aurélien Belot,Pascale Grosclaude,Nadine Bossard,Nadine Bossard,Eric Jougla,Ellen Benhamou,Patricia Delafosse,A.V. Guizard,Florence Molinié,Arlette Danzon,Simona Bara,Anne Marie Bouvier,Brigitte Trétarre,F. Binder-Foucard,Marc Colonna,L. Daubisse,G. Hedelin,Guy Launoy,N. Le Stang,Marc Maynadié,Alain Monnereau,Xavier Troussard,Jean Faivre,Albert Collignon,I. Janoray,Patrick Arveux,A. Buemi,N. Raverdy,Claire Schvartz,M. Bovet,L. Chérié-Challine,J. Estève,J. Estève,Laurent Remontet,Laurent Remontet,Michel Velten +35 more
TL;DR: The divergence of cancer incidence and mortality trends in France over the 1980-2005 period can be explained by the combined effects of a decrease in the incidence of the most aggressive cancers and an increase in the occurrence of less aggressive cancers, partly due to changes in medical practices leading to earlier diagnoses.
Journal ArticleDOI
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
Gemma Gatta,Riccardo Capocaccia,Laura Botta,Sandra Mallone,Roberta De Angelis,Eva Ardanaz,Harry Comber,Nadya Dimitrova,Maarit K. Leinonen,Sabine Siesling,Jan Maarten van der Zwan,Liesbet Van Eycken,Otto Visser,Maja Primic Žakelj,Lesley A. Anderson,F Bella,Innos Kaire,Renée Otter,Charles A. Stiller,Annalisa Trama,Monika Hackl,K. Henau,Nancy Van Damme,Zdravka Valerianova,M. Sekerija,Ladislav Dušek,Margit Mägi,Keiu Paapsi,Nea Malila,Michel Velten,Xavier Troussard,Véronique Bouvier,A.V. Guizard,Anne Marie Bouvier,Patrick Arveux,Marc Maynadié,Anne Sophie Woronoff,M. Robaszkiewicz,Isabelle Baldi,Alain Monnereau,Brigitte Trétarre,Marc Colonna,Florence Molinié,Simona Bara,Claire Schvartz,Bénédicte Lapôtre-Ledoux,Pascale Grosclaude,Roland Stabenow,Sabine Luttmann,Alice Nennecke,Jutta Engel,Gabriele Schubert-Fritschle,Jan Heidrich,Bernd Holleczek,Jon G. Jonasson,Kerri Clough-Gorr,Guido Mazzoleni,Adriano Giacomin,Antonella Sutera Sardo,Alessandro Barchielli,Diego Serraino,Paolo Collarile,Fabio Pannozzo,Paolo Ricci,M Autelitano,Gianbattista Spagnoli,Mario Fusco,M Usala,Francesco Vitale,Maria Michiara,Rosario Tumino,Lucia Mangone,Fabio Falcini,Stefano Ferretti,Rosa Filiberti,E Marani,Anna Luisa Caiazzo,Arturo Iannelli,Flavio Sensi,Silvano Piffer,M.A. Gentilini,Anselmo Madeddu,Antonino Ziino Colanino,S Maspero,Pina Candela,Fabrizio Stracci,Giovanna Tagliabue,Massimo Rugge,Paolo Baili,Pamela Minicozzi,Milena Sant,Carmen Tereanu,Silvia Francisci,Andrea Tavilla,Daniela Pierannunzio,Silvia Rossi,Mariano Santaquilani,Arnold Knijn,Santa Pildava,Giedre Smailyte,Neville Calleja,Dominic Agius,Tom Børge Johannesen,Jadwiga Rachtan,Stanislaw Gózdz,J. Błaszczyk,Kamila Kepska,Gonçalo Forjaz de Lacerda,Maria José Bento,Ana Miranda,Chakameh Safaei Diba,Tina Žagar,E. Almar,Nerea Larrañaga,Arantza Lopez de Munain,Ana Torrella-Ramos,José María Díaz García,Rafael Marcos-Gragera,María José Sánchez,Carmen Navarro,Diego Salmerón,Conchi Moreno-Iribas,Jaume Galceran,Marià Carulla,Mohsen Mousavi,Christine Bouchardy,Silvia Ess,Andrea Bordoni,Isabelle Konzelmann,Jem Rashbass,Anna Gavin,David H. Brewster,Dyfed Wyn Huws,Vincent K Y Ho,Ellen Benhamou +134 more
TL;DR: The estimates of the burden of rare cancers in Europe, their time trends in incidence and survival, and information about centralisation of treatments in seven European countries are updated to help improve case management and survival.
Journal ArticleDOI
Breast carcinoma survival in Europe and the United States
Milena Sant,Claudia Allemani,Franco Berrino,Michel P Coleman,Tiiu Aareleid,Gilles Chaplain,Jan Willem Coebergh,Marc Colonna,Paolo Crosignani,Arlette Danzon,Massimo Federico,L. Gafa,Pascale Grosclaude,G. Hedelin,J. Mace-Lesec'H,Carmen Martinez Garcia,Henrik Møller,Eugenio Paci,N. Raverdy,Brigitte Trétarre,Evelyn M. I. Williams +20 more
TL;DR: Breast carcinoma survival rates were found to be higher in the U.S. than in Europe.